Global Industry Overview - Biotech
Drug developers are capitalizing on the momentum within the biotechnology industry, driven by optimism fueled by corporate takeovers and a favorable market climate. Kyverna Therapeutics Inc. and Metagenomi Inc. are poised to be the fourth and fifth biotech companies to go public in 2024, following the success of three initial public offerings (IPOs) that collectively raised $786 million, marking the sector's strongest start since 2021.
The first three biotech IPOs of 2024 have demonstrated substantial gains, with ArriVent Biopharma Inc., Alto Neuroscience Inc., and CG Oncology Inc. experiencing share price increases ranging from 22% to 100% above their IPO prices. CG Oncology's significant rally, raising over $10 million, serves as an indication of investors' willingness to support companies with more advanced drug development stages.
A biotech exchange-traded fund has surged by 38% since October, propelled by major pharmaceutical companies like Novartis AG and Bristol Myers Squibb Co. engaging in significant takeovers. Industry experts anticipate a rise in venture capital-backed biotech IPOs, with a specific focus on later-stage companies and drugs presenting near-term catalyst opportunitie
Most Read
Other News
Health Minister holds talks with UNFPA Regional Director Florence Bauer
02.04.2026.16:51
The Minister of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Protection, Mikheil Sarjveladze, met with Florence Bauer, the Regional Director of the United Nations Population Fund (UNFPA) for Eastern Europe and Central Asia.
According to the Ministry of Health, the two discussed joint programmes supported by UNFPA aimed at advancing their shared goals.
During the meeting, Minister Sarjveladze highlighted the vital role of UNFPA’s support in safeguarding human rights and fostering demographic sustainability in Georgia.
“In addition, Mikheil Sarjveladze expressed his gratitude to Florence Bauer for the partnership and fruitful cooperation, emphasising that such productive meetings will pave the way for even more effective collaboration in the future,” the Ministry stated.
The discussions covered key issues including demographic sustainability, gender equality, and youth empowerment. They also reviewed ongoing cooperation within the framework of the UN Sustainable Development Cooperation Framework (2026-2030) and outlined plans for the next phase of activities. Both parties explored avenues for more active collaboration and outlined future joint initiatives.
The meeting, held at the Ministry of Health, was attended by representatives from the local UNFPA office.
